Today on Outsourcing-Pharma.com   Puerto Rico pursuing biologic bucks Galapagos branches out with new GSK deal William Ransom & Son recall false contaminated products Contract manufacturing news in brief Two early-phase CROs merge

Related Industry News   Eisai continues biologics push with $3.9bn MGI Pharma buy Abbott cuts jobs, closes plant in Ireland Almirall takes on big pharma in COPD Merck heads to Ireland for new 200m site

Breaking News on Outsourcing Pharma
Daily  Monday 10 December 2007		Forward to a colleague

	Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here Access Full Stories Puerto Rico pursuing biologic bucks Puerto Rico is making a concerted effort to attract biologic investment dollars onto the island as it falls foul of a retreat from pharma firms seeking solid dose manufacturing... Read Galapagos branches out with new GSK deal GlaxoSmithKline (GSK) is the latest drug firm to involve Galapagos in a new development partnership, in a deal worth up to €218m for the Belgian biotech... Read William Ransom & Son recall false contaminated products UK-based William Ransom & Son has been advised to voluntarily recall certain products following a false contamination scare at its Witham, Essex, facility... Read Contract manufacturing news in brief Vetter, New England Peptide, Urigen Pharmaceuticals, Servac, and Patheon have all recently announced contract manufacturing news... Read Two early-phase CROs merge Two US players in the early-phase contract research organisation (CRO) space have announced their intentions to merge... Read
	All News Headlines for: December | November | October
	Related Industry News Eisai continues biologics push with $3.9bn MGI Pharma buy Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and strengthen its oncology pipeline... Read Abbott cuts jobs, closes plant in Ireland Abbott is to shut its doors on its Galway, Ireland, facility - taking 500 jobs with it - as the market moves into murky waters over the future of vascular stents... Read Almirall takes on big pharma in COPD Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house... Read Merck heads to Ireland for new 200m site Merck has settled on a site in south east Ireland for a new vaccines and biologics facility, investing €200m ($280m) in its third facility on the island... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Previous Headlines Sanofi steps up Asian investment Sanofi-Aventis has opened its first Asian research and development centre in Goa, India, signalling its ambition to further tap in to this region's budding pharma scene... Read DSM and Arch go for API manufacturing deal DSM Anti-Infectives has signed up India's Arch Pharmalabs in a multi-year contract to manufacture generic active pharmaceutical ingredients (APIs)... Read BMS reveals plans to trim the fat Bristol-Myers Squibb (BMS) has finally detailed its plans to trim the fat and save cash, months after first revealing that big changes would be on the cards... Read Eisai selects Singapore as Asia trials hub Eisai is planning to step up its clinical research presence in Asia and has chosen Singapore as a hub from which to coordinate its research activities... Read Arius and Avid team up Arius Research and Avid Bioservices have joined forces in the manufacturing and development of an anticancer antibody... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com